{"subnetworks": [{"diseases": ["ALZHEIMERS DISEASE", "EPILEPSY", "LIVER DISEASE", "UNIPOLAR DEPRESSION", "PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS", "GAMBLING BEHAVIOUR", "BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "TINNITUS", "PAIN", "NEUROPATHIC PAIN", "OBSESSIVE-COMPULSIVE DISORDER", "SCHIZOPHRENIA", "AUTISM SPECTRUM DISORDER", "DIABETIC RETINOPATHY"], "links": [{"source": "ENSG00000014216", "type": "directed", "target": "ENSG00000126247"}, {"source": "ENSG00000014216", "target": "ENSG00000143801"}, {"source": "ENSG00000014216", "type": "directed", "target": "ENSG00000153113", "reverse": "rev-inhibitory"}, {"source": "ENSG00000014216", "type": "stimulatory", "target": "ENSG00000176749"}, {"source": "ENSG00000014216", "type": "inhibitory", "target": "ENSG00000183454"}, {"source": "ENSG00000080815", "target": "ENSG00000117362", "reverse": "rev-stimulatory"}, {"source": "ENSG00000080815", "type": "directed", "target": "ENSG00000138613", "reverse": "rev-stimulatory"}, {"source": "ENSG00000080815", "type": "directed", "target": "ENSG00000143801"}, {"source": "ENSG00000080815", "type": "stimulatory", "target": "ENSG00000162736", "reverse": "rev-stimulatory"}, {"source": "ENSG00000080815", "target": "ENSG00000186318"}, {"source": "ENSG00000080815", "type": "directed", "target": "ENSG00000205155", "reverse": "rev-dual"}, {"source": "ENSG00000111707", "target": "ENSG00000176749"}, {"source": "ENSG00000116032", "target": "ENSG00000183454"}, {"source": "ENSG00000117362", "type": "stimulatory", "target": "ENSG00000143801"}, {"source": "ENSG00000117362", "type": "stimulatory", "target": "ENSG00000162736", "reverse": "rev-stimulatory"}, {"source": "ENSG00000117362", "type": "stimulatory", "target": "ENSG00000205155"}, {"source": "ENSG00000126247", "type": "directed", "target": "ENSG00000153113"}, {"source": "ENSG00000126247", "type": "stimulatory", "target": "ENSG00000162909", "reverse": "rev-directed"}, {"source": "ENSG00000138613", "type": "stimulatory", "target": "ENSG00000143801"}, {"source": "ENSG00000138613", "type": "stimulatory", "target": "ENSG00000162736", "reverse": "rev-directed"}, {"source": "ENSG00000138613", "type": "stimulatory", "target": "ENSG00000205155", "reverse": "rev-directed"}, {"source": "ENSG00000143801", "target": "ENSG00000162736", "reverse": "rev-stimulatory"}, {"source": "ENSG00000143801", "target": "ENSG00000205155", "reverse": "rev-directed"}, {"source": "ENSG00000153113", "type": "inhibitory", "target": "ENSG00000162909", "reverse": "rev-directed"}, {"source": "ENSG00000162736", "type": "stimulatory", "target": "ENSG00000186318"}, {"source": "ENSG00000162736", "type": "directed", "target": "ENSG00000205155"}, {"source": "ENSG00000162909", "type": "stimulatory", "target": "ENSG00000176749"}, {"source": "ENSG00000162909", "target": "ENSG00000256812"}, {"source": "ENSG00000176884", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000198785"}, {"source": "ENSG00000176884", "target": "ENSG00000273079", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "INFECTION", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "CEREBRAL ATHEROSCLEROSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "AMANTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS"]}, {"indications": [{"efo_term": "SUICIDAL IDEATION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "KETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1714", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "INJURY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395091", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}], "max_phase": 4, "name": "MEMANTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["GAMBLING BEHAVIOUR", "CANCER"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 3, "name": "RAPASTINEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544917", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Protein", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "NRX-1074", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545230", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 2, "name": "AV-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545351", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "DIABETIC RETINOPATHY", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256818", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 3, "name": "TARENFLURBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190083", "mechanisms": ["Gamma-secretase modulator"], "genes": ["PSEN1", "APH1A", "APH1B", "PSEN2", "NCSTN", "PSENEN"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 3, "name": "SEMAGACESTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL520733", "mechanisms": ["Gamma-secretase inhibitor"], "genes": ["PSEN1", "APH1A", "APH1B", "PSEN2", "NCSTN", "PSENEN"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 1, "name": "BEGACESTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL463981", "mechanisms": ["Gamma-secretase inhibitor"], "genes": ["PSEN1", "APH1A", "APH1B", "PSEN2", "NCSTN", "PSENEN"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "AVAGACESTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090771", "mechanisms": ["Gamma-secretase inhibitor"], "genes": ["PSEN1", "APH1A", "APH1B", "PSEN2", "NCSTN", "PSENEN"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "FELBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "GW468816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1207366", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "TINNITUS", "stage": 3}], "max_phase": 3, "name": "NERAMEXANE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106798", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LANICEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107647", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364609", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Radiprodil", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182066", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "CERC-301", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068839", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}], "max_phase": 4, "name": "DEXTROMETHORPHAN POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201461", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 0, "name": "ELENBECESTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833309", "mechanisms": ["Beta-secretase 1 inhibitor"], "genes": ["BACE1"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [], "max_phase": 0, "name": "CNS-5161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41306", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBOGLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255840", "mechanisms": ["Glutamate [NMDA] receptor positive allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DELUCEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110814", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD8108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707355", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRAXOPRODIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17350", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVT-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545349", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": []}], "heat": 0.9537839845997368, "nodes": [{"assoc": 1.0, "id": "ENSG00000014216", "label": "CAPN1"}, {"assoc": 1.0, "id": "ENSG00000080815", "label": "PSEN1"}, {"assoc": 0.1718300653, "id": "ENSG00000111707", "label": "SUDS3"}, {"assoc": 1.0, "id": "ENSG00000116032", "label": "GRIN3B"}, {"assoc": 1.0, "id": "ENSG00000117362", "label": "APH1A"}, {"assoc": 1.0, "id": "ENSG00000126247", "label": "CAPNS1"}, {"assoc": 1.0, "id": "ENSG00000138613", "label": "APH1B"}, {"assoc": 1.0, "id": "ENSG00000143801", "label": "PSEN2"}, {"assoc": 1.0, "id": "ENSG00000153113", "label": "CAST"}, {"assoc": 1.0, "id": "ENSG00000162736", "label": "NCSTN"}, {"assoc": 1.0, "id": "ENSG00000162909", "label": "CAPN2"}, {"assoc": 1.0, "id": "ENSG00000176749", "label": "CDK5R1"}, {"assoc": 1.0, "id": "ENSG00000176884", "label": "GRIN1"}, {"assoc": 1.0, "id": "ENSG00000183454", "label": "GRIN2A"}, {"assoc": 0.950065642095, "id": "ENSG00000186318", "label": "BACE1"}, {"assoc": 1.0, "id": "ENSG00000198785", "label": "GRIN3A"}, {"assoc": 1.0, "id": "ENSG00000205155", "label": "PSENEN"}, {"assoc": 1.0, "id": "ENSG00000256812", "label": "CAPNS2"}, {"assoc": 1.0, "id": "ENSG00000273079", "label": "GRIN2B"}], "size": 19}, {"diseases": ["HYPOTENSION", "PAIN", "INGUINAL HERNIA", "OSTEOARTHRITIS", "BONE FRACTURE", "BREAST CARCINOMA", "INJURY", "PROSTATE CARCINOMA", "HALLUX VALGUS", "POST OPERATIVE NAUSEA AND VOMITING", "OSTEOARTHRITIS, HIP", "BREAST NEOPLASM", "CANCER", "CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE", "PREGNANCY", "EPILEPSY", "SEIZURES", "OPTIC NEURITIS", "OSTEOARTHRITIS, KNEE", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "POST-OPERATIVE SIGN OR SYMPTOM", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA", "CATARACT", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "DRUG DEPENDENCE", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "OBSESSIVE-COMPULSIVE DISORDER", "ALCOHOL DEPENDENCE", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "NICOTINE DEPENDENCE", "MIGRAINE DISORDER", "NEUROPATHY", "DIABETIC NEUROPATHY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "COMPLEX PARTIAL EPILEPSY", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "DYSURIA", "HIP FRACTURE"], "links": [{"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000129682", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000185313", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000161958", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000136531", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000007314", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000168356", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000183873", "type": "manual", "target": "ENSG00000161958"}], "drugs": [{"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "COUGH", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "PARATHYROID DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "URINARY TRACT INFECTION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "UTERINE FIBROID", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "TINNITUS", "stage": 0}], "max_phase": 4, "name": "LIDOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "INGUINAL HERNIA", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "HALLUX VALGUS", "stage": 3}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}], "max_phase": 4, "name": "BUPIVACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1098", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["HYPOTENSION", "PAIN", "INGUINAL HERNIA", "OSTEOARTHRITIS", "BONE FRACTURE", "BREAST CARCINOMA", "INJURY", "PROSTATE CARCINOMA", "HALLUX VALGUS", "POST OPERATIVE NAUSEA AND VOMITING", "OSTEOARTHRITIS, HIP", "BREAST NEOPLASM", "CANCER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 3}, {"efo_term": "DILATED CARDIOMYOPATHY", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIASTOLIC HEART FAILURE", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RANOLAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker", "Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN4A", "SCN5A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "MOOD DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 1}], "max_phase": 4, "name": "LAMOTRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EPILEPSY", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "PARTIAL EPILEPSY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATAXIA", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "RILUZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "BIPOLAR DISORDER", "UNIPOLAR DEPRESSION", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CANCER", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "LACOSAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "OSTEOARTHRITIS", "PARTIAL EPILEPSY", "MIGRAINE DISORDER", "NEUROPATHY", "NEUROPATHIC PAIN", "FIBROMYALGIA", "SEIZURES", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COMPLEX PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}], "max_phase": 4, "name": "ESLICARBAZEPINE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "FIBROMYALGIA", "MIGRAINE DISORDER", "BIPOLAR DISORDER", "COMPLEX PARTIAL EPILEPSY", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ZONISAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "EPILEPSY", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "SEIZURES", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 4, "name": "OXCARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "PARTIAL EPILEPSY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}], "max_phase": 4, "name": "PHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 4}], "max_phase": 4, "name": "CARBAMAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CATARACT", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "TETRACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CATARACT", "PAIN", "PRURITUS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "RUFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SEIZURES", "EPILEPSY", "LENNOX-GASTAUT SYNDROME", "PAIN"]}, {"indications": [{"efo_term": "HIP FRACTURE", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "INGUINAL HERNIA", "stage": 1}, {"efo_term": "PAIN", "stage": 0}], "max_phase": 4, "name": "ROPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1889140", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "INGUINAL HERNIA", "stage": 2}], "max_phase": 4, "name": "BUPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200396", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["INGUINAL HERNIA", "PAIN"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "RAXATRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544913", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["TRIGEMINAL NEURALGIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "PF-05089771", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545171", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "PREGNANCY", "stage": 3}], "max_phase": 4, "name": "LEVOBUPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["PREGNANCY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "MEPHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENACEMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL918", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ESLICARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL315985", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ETHOTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "DYSURIA", "stage": 3}], "max_phase": 4, "name": "PHENAZOPYRIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201022", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["DYSURIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "QUINIDINE POLYGALACTURONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201486", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "NW-3509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545207", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 1, "name": "AZD3161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545208", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-04531083", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544951", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [], "max_phase": 4, "name": "PROCAINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FOSPHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLOROPROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1611", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1769", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MORICIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200334", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "INDECAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LIDOCAINE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200409", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE GLUCONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200437", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200440", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MERETHOXYLLINE PROCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200443", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPARACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200464", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DYCLONINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200586", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETIDOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200597", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEXILETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200606", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENOXINATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXYLCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200715", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOCAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200773", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ARTICAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200819", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200841", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DISOPYRAMIDE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201020", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "NKTR-171", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545209", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707183", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Sodium channel protein type II alpha subunit blocker", "Sodium channel protein type III alpha subunit blocker"], "genes": ["SCN2A", "SCN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Sodium channel protein type XI alpha subunit  blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN11A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DSP-2230", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545012", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN9A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "XEN403", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545091", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG7893", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707353", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG6029", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707380", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIBUCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200612", "mechanisms": ["Sodium channel protein type V alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN5A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLECAINIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200822", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}], "heat": 0.8181818181818182, "nodes": [{"assoc": 1.0, "id": "ENSG00000007314", "label": "SCN4A"}, {"assoc": 1.0, "id": "ENSG00000136531", "label": "SCN2A"}, {"assoc": 1.0, "id": "ENSG00000144285", "label": "SCN1A"}, {"assoc": 1.0, "id": "ENSG00000153253", "label": "SCN3A"}, {"assoc": 1.0, "id": "ENSG00000168356", "label": "SCN11A"}, {"assoc": 1.0, "id": "ENSG00000169432", "label": "SCN9A"}, {"assoc": 1.0, "id": "ENSG00000183873", "label": "SCN5A"}, {"assoc": 1.0, "id": "ENSG00000185313", "label": "SCN10A"}, {"assoc": 1.0, "id": "ENSG00000196876", "label": "SCN8A"}, {"assoc": 0, "id": "ENSG00000129682", "label": "FGF13"}, {"assoc": 0, "id": "ENSG00000161958", "label": "FGF11"}], "size": 11}, {"diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY", "MIGRAINE DISORDER", "ANXIETY", "RENAL INSUFFICIENCY", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "MOVEMENT DISORDER", "STROKE", "GLIOBLASTOMA MULTIFORME", "FEVER", "INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "ANAL FISSURE", "KIDNEY STONE", "PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CONSTIPATION", "SKIN DISEASE", "ANGINA PECTORIS", "HYPERTENSION", "INTRACEREBRAL HEMORRHAGE", "CORONARY ARTERY DISEASE", "PROTEINURIA", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "ATRIAL FIBRILLATION"], "links": [{"source": "ENSG00000067191", "target": "ENSG00000141837", "reverse": "rev-directed"}, {"source": "ENSG00000139211", "target": "ENSG00000141837", "reverse": "rev-directed"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000165995"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000167535"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000182389"}, {"source": "ENSG00000148408", "type": "directed", "target": "ENSG00000165995", "reverse": "rev-directed"}, {"source": "ENSG00000148408", "type": "directed", "target": "ENSG00000167535"}, {"source": "ENSG00000151067", "type": "directed", "target": "ENSG00000167535"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "PANIC DISORDER", "stage": 3}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 1}, {"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "LEVETIRACETAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "ALCOHOL DEPENDENCE", "MOVEMENT DISORDER", "PARTIAL EPILEPSY", "STROKE", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "PRINZMETAL'S ANGINA", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 3}], "max_phase": 4, "name": "AMLODIPINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200402", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CORONARY ARTERY DISEASE", "PROTEINURIA", "ANGINA PECTORIS", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "STROKE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "BRAIN ANEURYSM", "stage": 1}], "max_phase": 4, "name": "NIMODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "ANAL FISSURE", "stage": 2}], "max_phase": 4, "name": "NIFEDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ANAL FISSURE", "PREMATURE BIRTH", "KIDNEY STONE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ISRADIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CARDIOVASCULAR DISEASE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "ANAL FISSURE", "stage": 3}, {"efo_term": "CONSTIPATION", "stage": 1}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "DILTIAZEM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1697", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CONSTIPATION", "ANAL FISSURE", "SKIN DISEASE", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "CLEVIDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "SCOLIOSIS", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "ZICONOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Protein", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 3}], "max_phase": 4, "name": "NICARDIPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200326", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "INTRACEREBRAL HEMORRHAGE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "CNV2197944", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545172", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "FELODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "NISOLDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Voltage-gated P/Q-type calcium channel alpha-1A subunit blocker", "Voltage-gated N-type calcium channel alpha-1B subunit blocker", "Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1A", "CACNA1B", "CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Z160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL604710", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VERAPAMIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DILTIAZEM MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200805", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMLODIPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200984", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}], "heat": 0.8828600688875, "nodes": [{"assoc": 1.0, "id": "ENSG00000067191", "label": "CACNB1"}, {"assoc": 0.0628805511, "id": "ENSG00000139211", "label": "AMIGO2"}, {"assoc": 1.0, "id": "ENSG00000141837", "label": "CACNA1A"}, {"assoc": 1.0, "id": "ENSG00000148408", "label": "CACNA1B"}, {"assoc": 1.0, "id": "ENSG00000151067", "label": "CACNA1C"}, {"assoc": 1.0, "id": "ENSG00000165995", "label": "CACNB2"}, {"assoc": 1.0, "id": "ENSG00000167535", "label": "CACNB3"}, {"assoc": 1.0, "id": "ENSG00000182389", "label": "CACNB4"}], "size": 8}, {"diseases": ["IRRITABLE BOWEL SYNDROME", "MARIJUANA DEPENDENCE", "SCHIZOPHRENIA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "OBSTRUCTIVE SLEEP APNEA", "ANOREXIA NERVOSA", "DRUG DEPENDENCE", "NAUSEA", "ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "SMOKING CESSATION", "PAIN", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "EPILEPSY", "NEOPLASM", "SEIZURES", "PARKINSON'S DISEASE", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "COCAINE DEPENDENCE", "OPIOID DEPENDENCE", "OBESITY", "TYPE II DIABETES MELLITUS", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "OBSESSIVE-COMPULSIVE DISORDER", "LIVER DISEASE", "CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA", "DIABETIC FOOT", "HUNTINGTON DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NEUROPATHIC PAIN", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "MYOCARDIAL INFARCTION", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS", "DYSPNEA", "MIGRAINE DISORDER", "AMBLYOPIA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "NARCOLEPSY", "METAMPHETAMINE DEPENDENCE", "STROKE", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER", "BIPOLAR DISORDER", "CANCER", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "DEMENTIA", "EATING DISORDER", "PROSTATE CARCINOMA", "INJURY", "FATIGUE", "POST-OPERATIVE SIGN OR SYMPTOM", "NICOTINE DEPENDENCE", "NARCOLEPSY WITH CATAPLEXY", "ORTHOSTATIC HYPOTENSION", "TINNITUS", "SLEEP APNEA", "EWING SARCOMA", "OVARIAN CARCINOMA", "MOOD DISORDER", "ESOPHAGEAL CARCINOMA", "HYPERSOMNIA", "INSOMNIA", "NOCTURIA", "PSYCHOSIS", "AUTISM", "DIABETES MELLITUS", "FISH-EYE DISEASE", "NAUSEA AND VOMITING", "MENTAL OR BEHAVIOURAL DISORDER", "TOURETTE SYNDROME", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "SCHIZOAFFECTIVE DISORDER", "PSORIASIS", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "INFERTILITY", "RESTLESS LEGS SYNDROME", "OVARIAN HYPERSTIMULATION SYNDROME", "BREAST CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "CONDUCT DISORDER", "NEONATAL ABSTINENCE SYNDROME", "GAMBLING BEHAVIOUR", "HIV INFECTION", "VOMITING", "INSULIN RESISTANCE", "LYMPHOID NEOPLASM", "FIBROMYALGIA", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY", "FEVER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "DIGESTIVE SYSTEM DISEASE", "ARTHRITIS", "CLEFT PALATE", "HYPERTENSION", "INFLUENZA INFECTION", "SEPSIS", "ABDOMINAL PAIN", "DYSMENORRHEA", "COMMON COLD", "HEMORRHAGE", "BACTERIAL MENINGITIS", "CERVICAL ADENOCARCINOMA", "GLAUCOMA", "TONSILLITIS", "BRAIN DISEASE", "PULPITIS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS, HIP", "RENAL COLIC", "ARTHRALGIA", "MYALGIA", "COUGH", "FROZEN SHOULDER", "TENDINOPATHY", "CYSTINOSIS", "DIABETIC NEUROPATHY", "DISORDER OF LIPID METABOLISM", "PRURITUS", "RHINITIS", "ATOPIC ECZEMA", "NEUROGENIC BLADDER", "ROSACEA", "SEBORRHEIC DERMATITIS"], "links": [{"source": "ENSG00000118432", "target": "ENSG00000128271"}, {"source": "ENSG00000118432", "type": "inhibitory", "target": "ENSG00000196689"}, {"source": "ENSG00000128271", "target": "ENSG00000149295"}, {"source": "ENSG00000142319", "target": "ENSG00000149295", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "COMMON COLD", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "ABDOMINAL PAIN", "stage": 3}, {"efo_term": "BACTERIAL MENINGITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 2}, {"efo_term": "CLEFT PALATE", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 2}, {"efo_term": "CERVICAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "TONSILLITIS", "stage": 2}, {"efo_term": "BRAIN DISEASE", "stage": 2}, {"efo_term": "PULPITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 2}, {"efo_term": "GLAUCOMA", "stage": 0}], "max_phase": 4, "name": "ACETAMINOPHEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112", "mechanisms": ["Vanilloid receptor opener"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["FEVER", "MIGRAINE DISORDER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "DIGESTIVE SYSTEM DISEASE", "ARTHRITIS", "CLEFT PALATE", "PATENT DUCTUS ARTERIOSUS", "HYPERTENSION", "INFLUENZA INFECTION", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "SEPSIS", "INJURY", "ABDOMINAL PAIN", "DYSMENORRHEA", "COMMON COLD", "HEMORRHAGE", "BACTERIAL MENINGITIS", "CERVICAL ADENOCARCINOMA", "GLAUCOMA", "TONSILLITIS", "BRAIN DISEASE", "PULPITIS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS, HIP", "RENAL COLIC"]}, {"indications": [{"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "DISORDER OF LIPID METABOLISM", "stage": 2}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 0}, {"efo_term": "MIGRAINE DISORDER", "stage": 0}, {"efo_term": "CYSTINOSIS", "stage": 0}, {"efo_term": "INJURY", "stage": 0}], "max_phase": 4, "name": "CAPSAICIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199", "mechanisms": ["Vanilloid receptor opener"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["PAIN", "ARTHRALGIA", "MYALGIA", "AMYOTROPHIC LATERAL SCLEROSIS", "OSTEOARTHRITIS", "COUGH", "PULMONARY HYPERTENSION", "ARTHRITIS", "FROZEN SHOULDER", "TENDINOPATHY", "PARKINSON'S DISEASE", "MIGRAINE DISORDER", "CYSTINOSIS", "PROSTATE CARCINOMA", "DIABETIC NEUROPATHY", "DISORDER OF LIPID METABOLISM", "PRURITUS", "INJURY", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}], "max_phase": 3, "name": "CANNABIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190461", "mechanisms": ["Cannabinoid CB1 receptor Negative allosteric modulator"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PAIN", "MARIJUANA DEPENDENCE", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "EPILEPSY", "NEOPLASM", "SEIZURES", "PARKINSON'S DISEASE", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "DRUG DEPENDENCE", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "COCAINE DEPENDENCE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "BRAIN NEOPLASM", "stage": 3}, {"efo_term": "DEMENTIA", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "FATIGUE", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 0}, {"efo_term": "PARKINSON'S DISEASE", "stage": 0}], "max_phase": 4, "name": "METHYLPHENIDATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "BIPOLAR DISORDER", "CANCER", "METAMPHETAMINE DEPENDENCE", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "DEMENTIA", "EATING DISORDER", "MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "PROSTATE CARCINOMA", "SICKLE CELL ANEMIA", "INJURY", "PARKINSON'S DISEASE", "FATIGUE", "ALZHEIMERS DISEASE", "POST-OPERATIVE SIGN OR SYMPTOM", "NICOTINE DEPENDENCE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "AUTISM", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "AGGRESSIVE BEHAVIOR", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AGITATION", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 3}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "POSTPARTUM DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ARIPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MENTAL OR BEHAVIOURAL DISORDER", "PSYCHOSIS", "TOURETTE SYNDROME", "DIABETES MELLITUS", "POST-TRAUMATIC STRESS DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "BRAIN NEOPLASM", "stage": 3}, {"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 3}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FATIGUE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "EWING SARCOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 1}, {"efo_term": "SLEEP APNEA", "stage": 1}, {"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 0}], "max_phase": 4, "name": "MODAFINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1373", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "COCAINE DEPENDENCE", "METAMPHETAMINE DEPENDENCE", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "FATIGUE", "NARCOLEPSY WITH CATAPLEXY", "ORTHOSTATIC HYPOTENSION", "TINNITUS", "POST-TRAUMATIC STRESS DISORDER", "SLEEP APNEA", "EWING SARCOMA", "STROKE", "ALZHEIMERS DISEASE", "OVARIAN CARCINOMA"]}, {"indications": [{"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "HYPERSOMNIA", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "FATIGUE", "stage": 3}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "NOCTURIA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}], "max_phase": 4, "name": "ARMODAFINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201192", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ESOPHAGEAL CARCINOMA", "HYPERSOMNIA", "INSOMNIA", "SCHIZOPHRENIA", "NARCOLEPSY WITH CATAPLEXY", "NON-SMALL CELL LUNG CARCINOMA", "UNIPOLAR DEPRESSION", "NEOPLASM", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER", "INJURY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "OBSTRUCTIVE SLEEP APNEA", "FATIGUE", "STROKE", "NOCTURIA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["Adenosine A2 receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}, {"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "DRONABINOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "MARIJUANA DEPENDENCE", "SCHIZOPHRENIA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "OBSTRUCTIVE SLEEP APNEA", "ANOREXIA NERVOSA", "DRUG DEPENDENCE", "NAUSEA", "ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "OVARIAN HYPERSTIMULATION SYNDROME", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 4, "name": "CABERGOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087", "mechanisms": ["Dopamine D2 receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "INFERTILITY", "RESTLESS LEGS SYNDROME", "OVARIAN HYPERSTIMULATION SYNDROME", "COCAINE DEPENDENCE", "BREAST CARCINOMA", "OBESITY", "ENDOMETRIOSIS"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "DEXTROAMPHETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "COCAINE DEPENDENCE", "METAMPHETAMINE DEPENDENCE", "STROKE", "SCHIZOPHRENIA", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "TOURETTE SYNDROME", "stage": 4}, {"efo_term": "CONDUCT DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AGITATION", "stage": 3}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}], "max_phase": 4, "name": "HALOPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "INFERTILITY", "stage": 4}, {"efo_term": "HYPERPROLACTINEMIA", "stage": 4}, {"efo_term": "HYPOGONADISM", "stage": 4}, {"efo_term": "GROWTH HORMONE EXCESS", "stage": 4}, {"efo_term": "ACROMEGALY", "stage": 4}], "max_phase": 4, "name": "BROMOCRIPTINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200503", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "INFERTILITY", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "MOOD DISORDER", "stage": 1}], "max_phase": 4, "name": "BUPROPION HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1698", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION", "LUNG CARCINOMA", "MOOD DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 4, "name": "PALIPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSYCHOSIS", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}], "max_phase": 4, "name": "BREXPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105760", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "INSOMNIA", "PSYCHOSIS", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "SPASTICITY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 1}], "max_phase": 4, "name": "NABILONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218896", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["NAUSEA", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "MARIJUANA DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 2}, {"efo_term": "CORONARY HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "REGADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}], "max_phase": 4, "name": "LISDEXAMFETAMINE DIMESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "EATING DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ILOPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "NAUSEA AND VOMITING", "stage": 2}], "max_phase": 4, "name": "PROCHLORPERAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "NAUSEA AND VOMITING", "PSYCHOSIS", "PAIN"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "ROSACEA", "stage": 2}, {"efo_term": "PRURITUS", "stage": 2}, {"efo_term": "SEBORRHEIC DERMATITIS", "stage": 2}], "max_phase": 3, "name": "PAC-14028", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707398", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "ROSACEA", "PRURITUS", "SEBORRHEIC DERMATITIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "ISTRADEFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 3, "name": "DASOTRALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301595", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "EATING DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 3}], "max_phase": 4, "name": "ASENAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544974", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}], "max_phase": 4, "name": "CHLORPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "NEONATAL ABSTINENCE SYNDROME"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "ROTIGOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "COUGH", "stage": 2}, {"efo_term": "RHINITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 1}], "max_phase": 2, "name": "SB-705498", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL207433", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["COUGH", "RHINITIS", "ATOPIC ECZEMA"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "TARANABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220360", "mechanisms": ["Cannabinoid CB1 receptor inverse agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "IBIPINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL412262", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "PRELADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240624", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 0}], "max_phase": 3, "name": "TOZADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105747", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "V81444", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545288", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "AMPHETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "AMPHETAMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "METHYLPHENIDATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "CANCER"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "DEXTROAMPHETAMINE SACCHARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200992", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "DEXTROAMPHETAMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544971", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "OBESITY", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 4, "name": "MAZINDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["OBESITY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CLOZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 3, "name": "BIFEPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218166", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200854", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSORIASIS", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE ENANTHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200951", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "PSORIASIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}], "max_phase": 4, "name": "PALIPERIDONE PALMITATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201732", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}], "max_phase": 4, "name": "LURASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615372", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "CARIPRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2024517", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}], "max_phase": 4, "name": "PRAMIPEXOLE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542257", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "HALOPERIDOL DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["CANCER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "SAF312", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544953", "mechanisms": ["Vanilloid receptor inhibitor"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER", "PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "AZD1386", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545039", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "PAIN"]}, {"indications": [{"efo_term": "COUGH", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "XEN-D0501", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707293", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["COUGH", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 2, "name": "SURINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189676", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SMOKING CESSATION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "Drinabant", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545166", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "VIPADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447664", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "DIABETIC FOOT", "stage": 2}], "max_phase": 2, "name": "SONEDENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950553", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545009", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545271", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "BVT.115959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545409", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "DEXMETHYLPHENIDATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL904", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "BUPROPION HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201735", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}], "max_phase": 4, "name": "SIBUTRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200765", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "METHAMPHETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["METAMPHETAMINE DEPENDENCE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LIAFENSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364614", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "PERPHENAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "TRIFLUPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "THIOTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 3}], "max_phase": 3, "name": "PRIDOPIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596802", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "METOCLOPRAMIDE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200940", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["POST OPERATIVE NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "ARIPIPRAZOLE LAUROXIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219425", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Unknown", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 3, "name": "PARDOPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103832", "mechanisms": ["Dopamine receptors; D2 & D3 partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "DROPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "APOMORPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1616", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "LEVOMEPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1764", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "ROPINIROLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200411", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 1}], "max_phase": 1, "name": "MAVATREP", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364618", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS"]}, {"indications": [], "max_phase": 3, "name": "OTENABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL562668", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NONABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106841", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD2207", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545289", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SAD448", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545387", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ST1535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197669", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "UK432097", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096896", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BINODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950554", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950649", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950651", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIETHYLPROPION HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1693", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMPHETAMINE ASPARTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200377", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMPHETAMINE ADIPATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200387", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENMETRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200483", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXTROAMPHETAMINE ADIPATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200782", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENDIMETRAZINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1898523", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MOLINDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200419", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200587", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENZQUINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200707", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLUPHENAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200792", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200856", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOTHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200902", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MESORIDAZINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201052", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201074", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE EDISYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201154", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "APLINDORE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104864", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "SARIZOTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146110", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACETOPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2360079", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Ordopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545010", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SB-773812", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Seridopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545388", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PERGOLIDE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200469", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOPERIDOL LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096643", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AMG-517", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL229430", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ABT-102", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398338", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GRC-6211", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545107", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PHE377", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545148", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NGD-8243", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545227", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "JTS-653", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545228", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DWP05195", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545229", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SYL-1001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707356", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "MR-1817", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707397", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}], "heat": 0.6591027406934, "nodes": [{"assoc": 0.239404955345, "id": "ENSG00000118432", "label": "CNR1"}, {"assoc": 0.1322635, "id": "ENSG00000128271", "label": "ADORA2A"}, {"assoc": 0.923845248122, "id": "ENSG00000142319", "label": "SLC6A3"}, {"assoc": 1.0, "id": "ENSG00000149295", "label": "DRD2"}, {"assoc": 1.0, "id": "ENSG00000196689", "label": "TRPV1"}], "size": 5}, {"diseases": [], "links": [{"source": "ENSG00000100979", "target": "ENSG00000130203"}, {"source": "ENSG00000130203", "type": "stimulatory", "target": "ENSG00000137642"}, {"source": "ENSG00000130203", "target": "ENSG00000234906", "reverse": "rev-directed"}], "drugs": [], "heat": 0.5296589457993249, "nodes": [{"assoc": 0.0581839984354, "id": "ENSG00000100979", "label": "PLTP"}, {"assoc": 1.0, "id": "ENSG00000130203", "label": "APOE"}, {"assoc": 1.0, "id": "ENSG00000137642", "label": "SORL1"}, {"assoc": 0.0604517847619, "id": "ENSG00000234906", "label": "APOC2"}], "size": 4}, {"diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION", "HYPERTENSION", "OVERACTIVE BLADDER", "GASTROPARESIS", "IRRITABLE BOWEL SYNDROME"], "links": [{"source": "ENSG00000101204", "target": "ENSG00000160716"}, {"source": "ENSG00000101204", "target": "ENSG00000163032"}, {"source": "ENSG00000160716", "target": "ENSG00000169684"}], "drugs": [{"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CERVICAL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 1}, {"efo_term": "SARCOIDOSIS", "stage": 1}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}], "max_phase": 4, "name": "NICOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "ISPRONICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188462", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 1}], "max_phase": 3, "name": "DEXMECAMYLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103881", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["HYPERTENSION", "OVERACTIVE BLADDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "POZANICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127071", "mechanisms": ["Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist", "Neuronal acetylcholine receptor; alpha6/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2", "CHRNA5"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "SOFINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL238465", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "NICOTINE POLACRILEX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201536", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 1}], "max_phase": 4, "name": "VARENICLINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062259", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "AZD1446", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2179529", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "GASTROPARESIS", "stage": 1}], "max_phase": 2, "name": "TC-6499", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545353", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["GASTROPARESIS", "IRRITABLE BOWEL SYNDROME"]}, {"indications": [], "max_phase": 2, "name": "TEBANICLINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430497", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ALTINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111659", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TC-2216", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504652", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CP-601927", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707250", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ABT-560", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707354", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 modulator"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}], "heat": 0.6414593229012501, "nodes": [{"assoc": 1.0, "id": "ENSG00000101204", "label": "CHRNA4"}, {"assoc": 1.0, "id": "ENSG00000160716", "label": "CHRNB2"}, {"assoc": 0.293615069383, "id": "ENSG00000163032", "label": "VSNL1"}, {"assoc": 0.272222222222, "id": "ENSG00000169684", "label": "CHRNA5"}], "size": 4}, {"diseases": ["ACNE", "ACUTE MYELOID LEUKEMIA", "LYMPHOMA", "NEOPLASM", "ROSACEA", "MULTIPLE MYELOMA", "LUNG CARCINOMA", "ACTINIC KERATOSIS", "NEUROBLASTOMA", "INFECTION", "HIV-1 INFECTION", "ALZHEIMERS DISEASE", "SKIN DISEASE", "PSORIASIS", "CARCINOMA", "ECZEMA", "CUTANEOUS LUPUS ERYTHEMATOSUS", "NON-SMALL CELL LUNG CARCINOMA", "SCHIZOPHRENIA", "ALOPECIA AREATA", "THYROID CARCINOMA", "BREAST CARCINOMA", "CUTANEOUS T-CELL LYMPHOMA", "PARKINSON'S DISEASE"], "links": [{"source": "ENSG00000077092", "type": "directed", "target": "ENSG00000143171"}, {"source": "ENSG00000143171", "target": "ENSG00000172819", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "CUTANEOUS T-CELL LYMPHOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "ALOPECIA AREATA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "THYROID CARCINOMA", "stage": 0}], "max_phase": 4, "name": "BEXAROTENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023", "mechanisms": ["Retinoid X receptor agonist"], "genes": ["RXRG"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "ACUTE MYELOID LEUKEMIA", "ALOPECIA AREATA", "THYROID CARCINOMA", "BREAST CARCINOMA", "CUTANEOUS T-CELL LYMPHOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "NEUROBLASTOMA", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ACTINIC KERATOSIS", "stage": 2}, {"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "INFECTION", "stage": 1}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 4, "name": "ISOTRETINOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL547", "mechanisms": ["Retinoic acid receptor agonist"], "genes": ["RARB", "RARG"], "type": "Small molecule", "diseases": ["LUNG CARCINOMA", "ACTINIC KERATOSIS", "NEUROBLASTOMA", "ACNE", "INFECTION", "HIV-1 INFECTION", "ALZHEIMERS DISEASE", "ROSACEA"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}], "max_phase": 4, "name": "TRETINOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38", "mechanisms": ["Retinoic acid receptor agonist"], "genes": ["RARB", "RARG"], "type": "Small molecule", "diseases": ["ACNE", "ACUTE MYELOID LEUKEMIA", "LYMPHOMA", "NEOPLASM", "ROSACEA", "MULTIPLE MYELOMA"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "SKIN DISEASE", "stage": 2}], "max_phase": 4, "name": "TAZAROTENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1657", "mechanisms": ["Retinoic acid receptor agonist"], "genes": ["RARB", "RARG"], "type": "Small molecule", "diseases": ["ACNE", "PSORIASIS", "CARCINOMA", "SKIN DISEASE"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ECZEMA", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "CUTANEOUS LUPUS ERYTHEMATOSUS", "stage": 2}], "max_phase": 4, "name": "ALITRETINOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705", "mechanisms": ["Retinoid receptor agonist"], "genes": ["RARB", "RXRG", "RARG"], "type": "Small molecule", "diseases": ["NEOPLASM", "PSORIASIS", "ECZEMA", "CUTANEOUS LUPUS ERYTHEMATOSUS"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "ADAPALENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1265", "mechanisms": ["Retinoic acid receptor agonist"], "genes": ["RARB", "RARG"], "type": "Small molecule", "diseases": ["ACNE", "SKIN DISEASE"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}], "max_phase": 4, "name": "ETRETINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464", "mechanisms": ["Retinoid receptor agonist"], "genes": ["RARB", "RXRG", "RARG"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}], "max_phase": 4, "name": "ACITRETIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1131", "mechanisms": ["Retinoid receptor agonist"], "genes": ["RARB", "RXRG", "RARG"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "IRX-4204", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75133", "mechanisms": ["Retinoid X receptor agonist"], "genes": ["RXRG"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [], "max_phase": 1, "name": "IRX4310", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545173", "mechanisms": ["Retinoic acid receptor antagonist"], "genes": ["RARB", "RARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "MOFAROTENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL146506", "mechanisms": ["Retinoid receptor modulator"], "genes": ["RARB", "RXRG", "RARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PALOVAROTENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105648", "mechanisms": ["Retinoic acid receptor gamma agonist"], "genes": ["RARG"], "type": "Small molecule", "diseases": []}], "heat": 0.23844450422866667, "nodes": [{"assoc": 0.229137, "id": "ENSG00000077092", "label": "RARB"}, {"assoc": 0.261196512686, "id": "ENSG00000143171", "label": "RXRG"}, {"assoc": 0.225, "id": "ENSG00000172819", "label": "RARG"}], "size": 3}, {"diseases": ["CONSTIPATION", "LIVER DISEASE", "DIGESTIVE SYSTEM DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "ALZHEIMERS DISEASE", "GASTROPARESIS", "GASTROESOPHAGEAL REFLUX DISEASE", "GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER", "UNIPOLAR DEPRESSION", "ASTHMA", "SMOKING CESSATION", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION", "TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA", "OBESITY", "EMPHYSEMA", "CHRONIC BRONCHITIS", "DRUG DEPENDENCE", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "ACUTE RESPIRATORY DISTRESS SYNDROME", "OVARIAN CYST", "DIABETIC FOOT", "HEART FAILURE", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY", "PAIN", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"], "links": [{"source": "ENSG00000164270", "target": "ENSG00000169252"}, {"source": "ENSG00000169252", "target": "ENSG00000188778"}], "drugs": [{"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 2}, {"efo_term": "RESPIRATORY FAILURE", "stage": 2}, {"efo_term": "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "stage": 1}, {"efo_term": "CONGENITAL MYASTHENIC SYNDROME", "stage": 1}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "ALBUTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "LEFT VENTRICULAR HYPERTROPHY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "MIRABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095212", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "PAIN", "LIVER DISEASE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 2}, {"efo_term": "HEMANGIOMA", "stage": 2}, {"efo_term": "SKIN ULCER", "stage": 2}], "max_phase": 4, "name": "TIMOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "OBESITY", "stage": 2}], "max_phase": 4, "name": "SALMETEROL XINAFOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082607", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBESITY", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}], "max_phase": 4, "name": "ALBUTEROL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201026", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 4, "name": "NADOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CARDIOVASCULAR DISEASE", "SMOKING CESSATION", "HEMANGIOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "VILANTEROL TRIFENATATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084172", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 4, "name": "INDACATEROL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789842", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "PROPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1671", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "stage": 1}], "max_phase": 4, "name": "TIMOLOL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200870", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "HEMANGIOMA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "PRUCALOPRIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117287", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["CONSTIPATION", "LIVER DISEASE"]}, {"indications": [{"efo_term": "GASTROPARESIS", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "VELUSETRAG", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2087337", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "GASTROPARESIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "PINDOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500", "mechanisms": ["Beta-2 adrenergic receptor partial agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}], "max_phase": 4, "name": "TERBUTALINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160544", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "METAPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200812", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "OVARIAN CYST", "stage": 1}, {"efo_term": "DIABETIC FOOT", "stage": 1}], "max_phase": 4, "name": "ESMOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201115", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["OVARIAN CYST", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "ARFORMOTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1951071", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "OLODATEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105743", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 2, "name": "BEDORADRINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}], "max_phase": 4, "name": "FORMOTEROL FUMARATE DIHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2303638", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "ABEDITEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039530", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD3199", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545103", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}], "max_phase": 4, "name": "CISAPRIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200788", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "METOCLOPRAMIDE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200940", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["POST OPERATIVE NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "NARONAPRIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103858", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 2}], "max_phase": 2, "name": "Revexepride", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545035", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["GASTROESOPHAGEAL REFLUX DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "CARMOTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094785", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PIRBUTEROL ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200444", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "NEBIVOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201731", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "LY377604", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2012520", "mechanisms": ["Beta-2 adrenergic receptor antagonist", "Beta-3 adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 3}], "max_phase": 4, "name": "LEVALBUTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062258", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "ISOPROTERENOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARTEOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201002", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 1}], "max_phase": 3, "name": "RITOBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107773", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "VIBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107826", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [], "max_phase": 4, "name": "TEGASEROD MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1516474", "mechanisms": ["Serotonin 4 (5-HT4) receptor partial agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Capeserod", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2027925", "mechanisms": ["Serotonin 4 (5-HT4) receptor partial agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SOTALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1700", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENBUTOLOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200363", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BITOLTEROL MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200405", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOBUTAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200418", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXPRENOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200745", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROTOKYLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200920", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METIPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200947", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALBUTEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201061", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201153", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RITODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201160", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBUNOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MILVETEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1940832", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GSK159802", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545087", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS190792", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545272", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200447", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RAFABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279260", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SOLABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL208427", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AMIBEGRON HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545437", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}], "heat": 0.7043726928116666, "nodes": [{"assoc": 0.113118078435, "id": "ENSG00000164270", "label": "HTR4"}, {"assoc": 1.0, "id": "ENSG00000169252", "label": "ADRB2"}, {"assoc": 1.0, "id": "ENSG00000188778", "label": "ADRB3"}], "size": 3}], "auto_delta": "0.00477426"}